Christopher Burks, MD
Orthopaedic Surgery · Vancleave, MSNPI 1861620148
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $13,882 of the $17,419 with a category attached, or 79.7%. 13 manufacturers reported payments, led by Spineart USA Inc at 57.0% of the total. Reporting peaked in 2023 at $7,198 and has fallen 97.2% since, to $199 in 2025.
Across 72 payments — averaging $241.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineart USA Inc$10K
- Alphatec Spine, Inc$4K
- Globus Medical$2K
- Amgen$323
- Smith+Nephew$206
- Sanara Medtech Inc.$112
- plus $269 from 7 others
What the payments were for
- Speaking & faculty fees$2061%
- Travel & lodging$13,88280%
- Food & beverage$3,33119%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineart USA Inc | 11 | $9,933 |
| Alphatec Spine, Inc | 5 | $4,110 |
| Globus Medical | 7 | $2,467 |
| Amgen | 37 | $323 |
| Smith+Nephew | 1 | $206 |
| Sanara Medtech Inc. | 1 | $112 |
| Abbott | 2 | $68 |
| Si-bone, Inc. | 3 | $58 |
| Surgalign Spine Technologies, Inc. | 1 | $56 |
| 4web, Inc. | 1 | $36 |
| Forte Bio-pharma LLC | 1 | $26 |
| Organogenesis Inc. | 1 | $15 |
| Electronic Waveform Lab, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,419 in reported general payments places this provider in the 75th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 102 | $2,364 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 112 | $1,065 |
| Tizanidine Hcl | 106 | $936 |
| Gabapentin | 54 | $374 |
| Cyclobenzaprine Hcl | 18 | $189 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $174 |
| Ondansetron OdtOndansetron | 11 | $132 |
| Meloxicam | 15 | $45 |
| Tramadol Hcl | 18 | $41 |
| Alprazolam | 14 | $5 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Vancleave
- Thomas LucakVancleave$12K
- David TaorminaVancleave$10K
- Matthew GravesJackson$1.2M
- George van OstenTupelo$322K
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jamey BurrowJackson$130K
- Jeff AlmandJackson$109K
- Spencer MontgomeryJackson$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.